Jeon J, D'Souza R, Pinto N, Ryu C-M, Park J, Yong D, Lee K
Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Molecular Phytobacteriology Laboratory, KRIBB, Daejeon, Korea.
J Appl Microbiol. 2016 Jul;121(1):68-77. doi: 10.1111/jam.13134.
The aim of this study was to characterize phenotypical properties, to analyse whole genomes of novel Acinetobacter baumannii phages infecting carbapenem-resistant Ac. baumannii (CRAB) and to evaluate their potential as antimicrobial alternatives to control Ac. baumannii in clinical settings.
The Ac. baumannii phages, Βϕ-R1215 and Βϕ-R2315, were isolated from sewage samples. These phages were characterized by transmission electron microscopy, host spectrum, the thermal/pH stability test, the bacterial lysis assay and the whole genome analysis. Both phages lysed 21 of 45 CRAB hosts, and showed high stability at various pH (pH 4-10) and temperature (25-60°C), and were strongly active against host bacteria in vitro. The genomes of Βϕ-R1215 and Βϕ-R2315 are linear double-strands of DNA with 44·866 and 44·846 bp respectively. These two genomes revealed high similarity at the DNA level, but the organization and direction of open reading frames were different.
The Ac. baumannii phages, Βϕ-R1215 and Βϕ-R2315, are novel lytic phages lysing CRAB strains which were isolated from respiratory samples of patients.
In vitro and in silico data showed that these novel Ac. baumannii phages, Βϕ-R1215 and Βϕ-R2315, have potential as antimicrobial alternatives to control CRAB in healthcare settings.
本研究旨在表征新型鲍曼不动杆菌噬菌体的表型特性,分析感染耐碳青霉烯鲍曼不动杆菌(CRAB)的新型鲍曼不动杆菌噬菌体的全基因组,并评估其作为抗菌替代品在临床环境中控制鲍曼不动杆菌的潜力。
从污水样本中分离出鲍曼不动杆菌噬菌体Βϕ-R1215和Βϕ-R2315。通过透射电子显微镜、宿主谱、热/ pH稳定性测试、细菌裂解试验和全基因组分析对这些噬菌体进行表征。两种噬菌体均可裂解45株CRAB宿主中的21株,在不同pH值(pH 4-10)和温度(25-60°C)下均表现出高稳定性,且在体外对宿主细菌具有强活性。Βϕ-R1215和Βϕ-R2315的基因组均为线性双链DNA,分别为44866和44846 bp。这两个基因组在DNA水平上显示出高度相似性,但开放阅读框的组织和方向不同。
鲍曼不动杆菌噬菌体Βϕ-R1215和Βϕ-R2315是从患者呼吸道样本中分离出的可裂解CRAB菌株的新型裂解性噬菌体。
体外和计算机模拟数据表明,这些新型鲍曼不动杆菌噬菌体Βϕ-R1215和Βϕ-R2315有潜力作为抗菌替代品在医疗环境中控制CRAB。